Table 1 Basic characteristics, spirometry and common inflammatory markers of all participants included in the study.
From: Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease
Parameter | Controls (n = 95) | COPD patients (n = 109) | P value |
---|---|---|---|
Age | 64 (46–83) | 65 (45–87) | 0.069 |
Sex | |||
Male | 49 | 69 | 0.121 |
Female | 46 | 40 | |
FEV1 (L) | 2.60 (2.12–3.19) | 1.08 (0.69–1.60) | < 0.001 |
FEV1 (% pred.) | 93.3 (86.4–104.2) | 40.8 (27.9–61.7) | < 0.001 |
FVC (L) | 3.35 (2.77–4.16) | 2.28 (1.74–2.77) | < 0.001 |
FEV1/FVC (%) | 80.6 (76.8–87.6) | 51.3 (40.7–58.7) | < 0.001 |
CRP (mg/L) | 1.47 (0.74–2.78) | 2.34 (1.15–5.67) | < 0.001 |
FIB (g/L) | 3.5 (3.1–3.8) | 3.8 (3.4–4.5) | < 0.001 |
WBC (× 109/L) | 6.14 (5.14–7.42) | 7.57 (6.55–8.95) | < 0.001 |
Smoking status | |||
Current smokers | 47 | 37 | < 0.001 |
Former smokers | 0 | 90 | |
Never smokers | 48 | 10 |